BMY - Bristol-Myers Squibb Co
This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2018 it was held by 6 managers with an aggregate reported value of $2.61B, which is 0.34% of the combined portfolio.
As of Q4 2018, 6 tracked institutional managers held BMY (Bristol-Myers Squibb Co) with an aggregate reported value of $2.61B — 0.34% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BMY — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2018
- Ticker
- BMY
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 2.03% | Add +29.2% | 42,587,957 | $2.21B |
| 2 | Bill Nygren - Oakmark Funds | 0.76% | Reduce -9.7% | 7,242,366 | $376.46M |
| 3 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.18% | Reduce -0.5% | 255,356 | $13.27M |
| 4 | Jensen Investment Management - Jensen Investment Management | 0.02% | - | 26,000 | $1.35M |
| 5 | Kahn Brothers Group - Kahn Brothers Group | 0.19% | - | 19,950 | $1.04M |
| 6 | David Katz - Matrix Asset Advisors | 0.15% | Reduce -11.6% | 15,234 | $792K |
Loading holder history for BMY…